GBM AGILE: A global, phase II/III adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma.

被引：0

作者：

Buxton, Meredith Becker

Alexander, Brian Michael

Berry, Donald A.

Cavenee, Webster K.

Colman, Howard

De Groot, John Frederick

Ellingson, Benjamin M.

Gordon, Gary B.

Khasraw, Mustafa

Lassman, Andrew B.

Li, Wenbin

Lim, Michael

Mellinghoff, Ingo K.

Perry, James R.

Sulman, Erik P.

Tanner, Kirk

Weller, Michael

Wen, Patrick Y.

Yung, W. K. Alfred

Cloughesy, Timothy Francis

机构：

[1] UC San Francisco, San Francisco, CA USA

[2] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA

[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[4] Univ Calif San Diego, La Jolla, CA 92093 USA

[5] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[6] Univ Texas Houston, MD Anderson Canc Ctr, Dept Neurooncol, 1515 Holcombe Blvd, Houston, TX 77030 USA

[7] Univ Calif Los Angeles, Los Angeles, CA USA

[8] AbbVie, N Chicago, IL 60064 USA

[9] Univ Sydney, Royal North Shore Hosp, St Leonards, NSW, Australia

[10] Columbia Univ, Irving Med Ctr, New York, NY USA

[11] Capital Med Univ, Beijing Shijitan Hosp, Dept Glioma, Beijing, Peoples R China

[12] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA

[13] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[14] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada

[15] Natl Brain Tumor Soc, Newton, MA USA

[16] Univ Hosp, Dept Neurol, Lab Mol Neurooncol, Zurich, Switzerland

[17] Univ Zurich, Zurich, Switzerland

[18] Harvard Med Sch, Dana Farber Brigham & Womens Canc Ctr, Boston, MA 02115 USA

[19] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS2579

引用

页数：2